Updated on 29 October 2012
What do you think is the strength of Shimadzu?
Shimadzu is very strong in LCMS, GCMS, Single Quad GCMS, Chromatography, Single Quad LCMS, Spectrophotometers. We do have the largest market share in chromatography and spectrophotometers, but we want to expand further. We have a market share of 35 percent in chromatography with Shimadzu crossing 14000 HPLC system installations to date in India. The single Quad MS market has very few players in this space so our share would be around 35-40 percent.
Shimadzu has had a very strong and unique relationship with its distributors. Can you elaborate about it?
In the analytical landscape, the Shimadzu family consists of Shimadzu India itself, plus our marketing partners Spinco, Toshvin and Swan and Saksham. This makes it one of the largest combined forces for Shimadzu products in India. We have adopted this model of partnering with our distributors, as we want to leverage their market reach and experience.
What are the trends you see in the market and what are your future plans for growth?
The trend we observe is that people are now looking for more high end instruments such as MS as compared to chromatography systems before. The depreciating rupee has affected our operations, however as the generics and biosimilars industry grows, we anticipate a corresponding increase in the need for sophisticated instruments thus fueling further growth. Most of the developed countries have already established their use of this technology. So its emerging markets such as India that hold a lot of promise and have a lot of demand.
We are aiming at 15-20 percent growth over the next year, building on our expanded MS portfolio as well as our other initiatives. Also we are in the midst of planning mini seminars on different issues and other activities to penetrate more deeply into our target base.